{
    "organizations": [],
    "uuid": "ca0a7d522f727161b60d78c1af37abfaf36b669e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-poxel-presents-preclinical-proof-o/brief-poxel-presents-preclinical-proof-of-concept-data-for-pxl770-idUSFWN1QH02B",
    "ord_in_thread": 0,
    "title": "BRIEF-Poxel Presents Preclinical Proof-Of-Concept Data For Pxl770",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - POXEL SA:\n* POXEL PRESENTS PRECLINICAL PROOF-OF-CONCEPT DATA FOR PXL770 IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) AT GLOBAL NASH CONGRESS 2018\n* PXL770 IS OBSERVED TO SIGNIFICANTLY REDUCE LIVER STEATOSIS AND NAS SCORE FOLLOWING 8 WEEKS OF TREATMENT VERSUS CONTROL\n* PXL770 IS OBSERVED TO SIGNIFICANTLY REDUCE EXPRESSION OF A PANEL OF KEY GENES ASSOCIATED WITH FIBROSIS\n* WE ARE PLANNING TO INITIATE A PHASE 2A PROOF-OF-CONCEPT STUDY IN PATIENTS WITH NAFLD -CEO\n* STUDY IS EXPECTED TO BEGIN DURING SECOND HALF OF 2018 * WE ARE ALSO EXPLORING OTHER METABOLIC DISEASES FOR PROOF-OF-CONCEPT STUDIES FOR PXL770 -CEO Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-27T15:58:00.000+02:00",
    "crawled": "2018-02-28T12:50:28.033+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "poxel",
        "sa",
        "poxel",
        "present",
        "preclinical",
        "data",
        "pxl770",
        "steatohepatitis",
        "nash",
        "global",
        "nash",
        "congress",
        "pxl770",
        "observed",
        "significantly",
        "reduce",
        "liver",
        "steatosis",
        "na",
        "score",
        "following",
        "week",
        "treatment",
        "versus",
        "control",
        "pxl770",
        "observed",
        "significantly",
        "reduce",
        "expression",
        "panel",
        "key",
        "gene",
        "associated",
        "fibrosis",
        "planning",
        "initiate",
        "phase",
        "2a",
        "study",
        "patient",
        "nafld",
        "study",
        "expected",
        "begin",
        "second",
        "half",
        "also",
        "exploring",
        "metabolic",
        "disease",
        "study",
        "pxl770",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}